Nasdaq GlobeNewswire

Sky9 Capital Closes New Fund on $200 Million Hard Cap

Del

HONG KONG, April 24, 2018 (GLOBE NEWSWIRE) -- Sky9 Capital announced today that it has completed the final closing of Sky9 Capital Fund III, L.P. with total capital commitments of $200 million.  With support from a strong group of world-class institutional investors, family foundations and entrepreneurs, the fund invests mainly in China-based businesses with a focus on early-stage companies in the internet, enterprise, and deep technology sectors.  Ron Cao, Founder & Managing Director, has over 18 years of extensive experience in venture capital and a track record of investing and growing successful China-based companies. 

The Sky9 team includes an experienced group of technologists, entrepreneurs and investors who have participated previously in the early-stage investments of some of the biggest technology companies in China including: DaVdian, eBroker, FaceU/Toutiao, FangDD, Innolight, Meituan/Dianping, ManBang Group, PPDai, PinDuoDuo, QingCloud, Rong360, Tujia, ZhaoYouWang and others.  With presence in Beijing, Shanghai, Shenzhen, and Silicon Valley, the firm has made a number of investments in the new fund including: ZhaoYouWang, the leading B2B e-commerce platform for the petroleum industry; eBroker, China's largest online marketplace for wealth management; Home, the leading social e-commerce platform for home furnishing; and Energy Monster, a power bank sharing platform.  Continuing its focus on early-stage and high-impact technology companies, Sky9 Capital invests between $1M to $10M in seed and Series A rounds, and $10M+ for expansion-stage companies.

"Sky9 has an exceptional team, and we have the experience and the commitment to continue to explore and invest in the biggest technology opportunities in China today," said Ron Cao. "The size and scale of the China internet and technology space continue to be unprecedented.  We are honored to have the chance to work with some extraordinary entrepreneurs in building exceptional companies together."

"Ron was a lead venture investor in the early-stage financing of our company," said Cliff Zhang, Co-founder & CEO of PPDai, a leading FinTech platform in China. "He has helped us tremendously over the years as we built out our business.  We look forward to our continued partnership with Sky9's new fund."  

"Sky9 Capital is eBroker's most important investor and partner," said Max He, Founder & CEO of eBroker, China's leading online wealth management platform. "In addition to providing advice and strategic planning, Sky9 focuses on building long-term value and is a true partner in growing together.  Congratulations to Ron and team for the successful fundraise."

For more information, please visit www.sky9capital.com.

About Sky9 Capital:

Sky9 Capital is a leading venture capital firm focused on investing in early-stage internet, enterprise and deep-tech start-ups in China. The firm invests with a systematic, analytical and conviction-based approach, focused on drawing deep market insights and discovering China's top talents. These principles guide our presence in Beijing, Shanghai, Shenzhen, and Silicon Valley as we support the innovators who will shape our future.  Through many years of cultivating deep relationships in the internet and technology sector and through its network of advisors, limited partners and strategic partners, the Sky9 team closely collaborates and shares resources with China's industry leaders like Baidu, Alibaba, Tencent, Toutiao, Meituan/Dianping, PinDuoDuo, Ctrip, PPDai, Rong360, Xiaomi and more.  For more information, please visit www.sky9capital.com.

Contact:

Cindy Chen
T: (86) 21 5238 3699
E: cindy@sky9capital.com

A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/8118babc-12f8-4e57-8275-56eba9528a2d




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sky9 Capital via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Atico Reports Consolidated Financial Results for the First Quarter of 201824.5.2018 22:30Pressemelding

(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the "Company" or "Atico") (TSX.V:ATY) (OTC:ATCMF) today announced its financial results for the three months ended March 31, 2018, posting a net income of $0.4 million. Fernando E. Ganoza, CEO and Director, commented, "The strong production and all-in sustaining cash cost of $1.85 achieved this quarter is not reflected in the financial results as a large concentrate shipment was delayed to the second quarter, along with the revenue associated with those tonnes. The shipping schedule is expected to stabilize during the second quarter, where we will then benefit from the additional shipped concentrate and recognized revenue. We anticipate strong financial results in the next quarter." Mr. Ganoza continued, "Our emphasis will continue to be on further strengthening our balance sheet, improving production costs and most importantly regional

Luxembourg Announced as SNOMED International's Newest Member24.5.2018 15:16Pressemelding

London, United Kingdom, May 24, 2018 (GLOBE NEWSWIRE) -- SNOMED International and Agence eSanté Luxembourg are pleased to announce that Luxembourg has joined the organization as its thirty-second Member. Luxembourg, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority. Agence eSanté, Luxembourg's national agency for the exchange and sharing of medical data, has set an overall mission to facilitate clinical information exchange both within Luxembourg and across other international actors. To work towards this reality, the agency has taken part in discussions about standardization across Europe, a contributing building block achieved with its membership in SNOMED International. With their membership, Agence eSanté has committed their support for the use of structured clinical terminology. When applied to the health sector, interoperability ensures that information systems, and through them h

SEMAFO Signs Underground Mining Services Contract with AUMS24.5.2018 14:00Pressemelding

MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- SEMAFO Inc. (TSX:SMF) (OMX:SMF) reports that it has signed a mining services contract with African Underground Mining Services ("AUMS") to provide turnkey mining services for Siou underground. AUMS is a well-known and reputable mining contractor with underground experience in Burkina Faso and across Africa. Under the mining services contract, AUMS will be responsible for supplying the mining fleet and a skilled labour force for Siou underground in addition to ensuring development, production and auxiliary services. SEMAFO will provide technical services including geology and engineering as well as leveraging the existing surface infrastructure at Mana. The mining services contract has a term of 70 months. The economic terms of the mining services contract are consistent with the economics presented in the Mana pre-feasibility study filed March 29, 2018 on SEDAR. Preparatory work has already commenced on Siou underground with full project deplo

Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors24.5.2018 13:00Pressemelding

- IND Accepted in April by the U.S. FDA for MCLA-158 - UTRECHT, The Netherlands, May 24, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the first patient has been dosed in a Phase 1, first-in human clinical trial of MCLA-158 in patients with solid tumors with an initial focus on metastatic colorectal cancer. The trial will be conducted in Europe, where several Clinical Trial Applications (CTAs) have been approved to date. The Company also announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for MCLA-158, which was accepted by the FDA in April 2018. With this acceptance, Merus plans to open additional sites for this trial in the United States. MCLA-158 is designed to bind to cancer stem cells expressing leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) and epidermal grow

PRA Named International Clinical Research Company of the Year24.5.2018 10:00Pressemelding

RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the fifth year in a row that PRA has received this award. "This award celebrates excellence in the clinical research industry and we are honored to once again be recognized by our peers," said Colin Shannon, President and Chief Executive Officer. "This award is possible thanks to the incredibly talented PRA team members we have working around the world who are deeply committed to their work in bringing new and life-saving therapies to the patients who need them." PRA also swept the Clinical Research Associate and Clinical Trial Administrator categories capturing a total of 11 awards. These awards follow PRA's recognition earlier this month in the PharmaTimes Americas competition where PRA also received 11 awards, including Company of the Year. The PharmaTimes, International Cli

Early Warning Report23.5.2018 20:05Pressemelding

VANCOUVER, British Columbia, May 23, 2018 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE:FSM) (TSX:FVI) announces that pursuant to a warrant exercise, it has acquired for a purchase price of C$803,571, direct ownership of 5,357,142 common shares (the "Shares") of Prospero Silver Corp. ("Prospero"), of 510 West Georgia Street, Suite 1800, Vancouver, BC V6B 0M3, at a price of C$0.15 per Share. Immediately following this transaction, Fortuna owned 10,714,284 common shares of Prospero, representing 22.74% of the issued and outstanding common shares of Prospero. Immediately prior to the transaction, Fortuna owned 5,357,142 common shares and 5,357,142 common share purchase warrants. The Shares were acquired by Fortuna for investment purposes, and depending on market and other conditions, it may from time to time in the future increase or decrease its ownership, control or direction over securities of Prospero through market transactions, private agreements, or otherwise. Fortuna has fil

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom